Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Documented history of moderately severe or severe hemophilia B (FIX:C less than or equal to 2%)~* Male subjects, aged 6 years to 65 years.~* Subjects with a minimum of 12 bleeding episodes, 6 of which must be joint bleeds, in the 12 months before screening.~Exclusion Criteria:~* Subjects currently utilizing FIX primary prophylaxis.~* Subjects with HIV+ who have a CD4 count less than 200~* Subjects with hepatic or renal impairment.~* Prothrombin time or International Normalized Ration more than 1.5 times the upper limit of normal.~* Major surgery or an orthopedic surgical procedure within the past 3 months or is planned within the duration of participation in this study.~* Past history of, or current FIX inhibitor.~* Hypersensitivity to any FIX product or hamster protein.~* Exposure to any investigational drug, except for rFIX-R, or device within 30 days of providing consent/assent (as appropriate) for this study.~* Bleeding disorders other than hemophilia B.~* Concurrent inflammatory disease that in the investigator's judgment could confound the study results.

- Gender: MALE
- Minimum Age: 6 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): None
- B (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).